Birmingham Health Partners (University of Birmingham, University Hospitals Birmingham NHS Foundation Trust, and Birmingham Women’s and Children's NHS Foundation Trust), the Institute of Translational Medicine (ITM) and the BioHub Birmingham, among many other centres of research and practice excellence all within close proximity to BHIC.

It will build on BHP’s integrated clinical-academic vision to deliver research that matters, making BHIC an exciting proposition as part of the evolution of life sciences in not only Birmingham but the wider region and UK.

The campus is being delivered through a long-term collaboration between the University of Birmingham, as landowner, and experienced investor-developers Bruntwood SciTech. It will become the only science park in the region dedicated to health and life sciences, sitting at the heart of a critical cluster of health excellence, led by BHP, creating opportunities for transformative collaborations between businesses, the University and NHS partners.

This will be a pioneering and globally significant location that brings together outstanding researchers, clinicians, policy makers and industry to rapidly translate scientific and clinical insights into patient benefit and economic growth. It will reinforce Birmingham’s global role, supporting innovative new partnerships and leveraging strong existing collaborations. Working with and for our large, diverse regional patient and public communities, it will be unparalleled in its ability to co-create dynamic solutions to some of the biggest challenges in life sciences and healthcare. It will benefit from outstanding clinical data integration and analytics, real world evidence and patient engagement.

To find out more about the extensive and innovative life sciences research happening at Birmingham, visit the life sciences website.

The Birmingham Health Innovation Campus will align with the broader life sciences expertise and infrastructure across the West Midlands and help establish Birmingham as a leading economic hub for life sciences. There are already 22,000 people employed in the sector across the region and more than 600 companies working in this area. The development of the park will afford industry greater access to leading research and facilities, investment prospects and the opportunity to develop their own facility spaces. This will give our local enterprises the edge in a competitive sector and promote job creation. Our vision is to attract the establishment of new SMEs and investment from large pharma and biotechnology firms. This will further enhance the region’s status as an internationally recognised hub for clinical academia. 

BHIC will:

• Offer precision medicine using personalised approaches to trial design for developing and testing new treatments and technologies.
• Use integrated data to drive improvements in healthcare through a greater understanding of the causes and potential treatments of disease.
• Train the workforce of the future to deliver multidisciplinary research and healthcare.

This signature facility will be the focal point of the development, providing up to 6,000sqm of innovation, co-creation and incubation space within our Phase 1 building.

The Precision Health Technologies Accelerator (PHTA) will be dedicated to the rapid development and translation of innovative therapies and technologies from concept to clinical evaluation. By creating new opportunities for businesses and entrepreneurs to innovate and grow, and for clinical-academics in the region to commercialise their ideas, it will accelerate our ambition to be a research and innovation leader in health and life sciences. 

The PHTA builds on BHP’s nationally-recognised strengths and will support businesses through access to expertise in: 

• the development and delivery of complex clinical trials
• complex diagnostics, multi-omics analysis and heath data
• device evaluation and testing
• regulatory science and innovation

The PHTA will provide the early incubation, grow-on space and innovation services for businesses working across biopharma, advanced therapies, diagnostics, digital health and healthcare technologies to accelerate the development and delivery of new drugs, diagnostics and devices into clinic. Its incubation services for early-stage businesses are set to include wet labs, dry labs and office spaces, and prototype development facilities.

And, by putting the patient at the heart of all our activity, we will focus on the innovations that address prevalent health burdens in our region’s population – with the ultimate aim of scaling these solutions to the rest of the UK and potentially wider world.

For more details on the Precision Health Technologies Accelerator contact us using the details below.

Will there be space on the Birmingham Health Innovation Campus for companies to locate?

Yes. The park will be comprised of research and development and service facilities including office spaces, laboratories and co-creation/co-development spaces. Please contact us for more information.

What are the timelines for the development?

It is anticipated that phased construction will start on site in mid 2021. Other opportunities are available in the meantime; we are currently developing partnerships and activities in areas such as the design and delivery of clinical trials and genomics sciences. Please contact us if you would like to find out more about these activities and partnering with us.

Can I be an investor in BHIC?

There are still opportunities for partners wishing to invest in the development of the park and we are happy to discuss these with interested parties. Please contact us for more information.

What are the main benefits of locating on BHIC?

The location of BHIC at the confluence of the University of Birmingham campus, University Hospitals Birmingham and Birmingham Women’s and Children’s NHS Foundation Trusts will facilitate unrivalled access to the infrastructure of BHP.

This will be a pioneering site that brings together outstanding researchers, clinicians, policy makers and industry to rapidly translate scientific and clinical insights into patient benefit and economic growth. It will reinforce Birmingham’s ability to support innovative new partnerships and leverage strong existing collaborations. All these factors make BHIC an exciting proposition as part of the evolution of life sciences in not only Birmingham but the wider region and UK.

July 2020: Download our BHIC Project Update (291KB PDF) to learn more about our plans, including the Resilience in Supply Chains for Med Tech Manufacturing (ReSCue) project, which will support manufacturing businesses and supply chains to diversify, scale-up and increase their resilience.

October 2019 – it has been announced that Birmingham Precision Medicine Centre (BPMC) will be located on the park when it opens in 2022. For further information please see the Birmingham Health Partners blog or download our BPMC leaflet.

If you would like to contact us with any queries regarding the park, please fill in the form below. Alternatively, please email the BHIC Project Office via the email provided. 

BHIC Project Office

Room CG27,
Medical School
Vincent Drive
University of Birmingham
Edgbaston
Birmingham
B15 2SQ

Dr Steve Taylor

Director of Strategy & Operations Birmingham Health Innovation Campus